Eudaimonia Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.01M | Buy |
1,045
+131
| +14% | +$126K | 0.54% | 54 |
|
|
2023
Q4 | $803K | Buy |
914
+11
| +1% | +$9.66K | 0.52% | 60 |
|
|
2023
Q3 | $743K | Hold |
903
| – | – | 0.52% | 57 |
|
|
2023
Q2 | $649K | Buy |
903
+24
| +3% | +$17.2K | 0.44% | 70 |
|
|
2023
Q1 | $722K | Sell |
879
-20
| -2% | -$16.4K | 0.49% | 60 |
|
|
2022
Q4 | $649K | Sell |
899
-44
| -5% | -$31.7K | 0.44% | 67 |
|
|
2022
Q3 | $650K | Sell |
943
-167
| -15% | -$115K | 0.45% | 55 |
|
|
2022
Q2 | $656K | Sell |
1,110
-17
| -2% | -$10K | 0.45% | 63 |
|
|
2022
Q1 | $787K | Sell |
1,127
-327
| -22% | -$228K | 0.45% | 62 |
|
|
2021
Q4 | $918K | Buy |
+1,454
| New | +$918K | 0.54% | 48 |
|